» Articles » PMID: 6379946

Macular Edema. A Complication of Diabetic Retinopathy

Overview
Journal Surv Ophthalmol
Specialty Ophthalmology
Date 1984 May 1
PMID 6379946
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic macular edema is the leading cause of decreased vision from diabetic retinopathy. This decreased vision is caused by an increase in extracellular fluid within the retina distorting the retinal architecture and frequently taking on a pattern of cystoid macular edema. This fluid accumulates within the retina because of the breakdown of the barriers within the retinal blood vessels and possibly the pigment epithelium. Diabetic macular edema tends to be a chronic disorder. Although spontaneous recovery is not an uncommon occurrence, over one-half of diabetics with macular edema will lose two or more lines of visual acuity within two years. The most promising treatment for diabetic macular edema has been photocoagulation. It is recommended that in all patients with diabetic macular edema attempts be made to normalize elevated blood glucose, decrease elevated blood pressure, and improve cardiac or renal status. Reduction of serum lipids by diet or pharmacologic means is an unproven treatment at this time. The Early Treatment Diabetic Retinopathy Study hopefully will provide more definitive information as to whether photocoagulation is effective in various subgroups of patients with diabetic macular edema.

Citing Articles

Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).

Varra F, Varras M, Varra V, Theodosis-Nobelos P Mol Med Rep. 2024; 29(6).

PMID: 38606791 PMC: 11025031. DOI: 10.3892/mmr.2024.13219.


Evaluation of the effect of intravitreal injections on corneal epithelial, scleral and limbal region changes in diabetic retinopathy by AS-OCT.

Cinar A, Kupeli Cinar A, Guclu H Int Ophthalmol. 2024; 44(1):31.

PMID: 38329554 DOI: 10.1007/s10792-024-02947-8.


Non-Invasive Treatment of Early Diabetic Macular Edema by Multiwavelength Photobiomodulation with the Valeda Light Delivery System.

Kaymak H, Munk M, Tedford S, Croissant C, Tedford C, Ruckert R Clin Ophthalmol. 2023; 17:3549-3559.

PMID: 38026594 PMC: 10676639. DOI: 10.2147/OPTH.S415883.


Determinants of diabetic retinopathy in Ethiopia: A systematic review and meta-analysis.

Azagew A, Yohanes Y, Beko Z, Ferede Y, Mekonnen C PLoS One. 2023; 18(6):e0286627.

PMID: 37289766 PMC: 10249865. DOI: 10.1371/journal.pone.0286627.


Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant.

Baillif S, Staccini P, Weber M, Delyfer M, Le Mer Y, Gualino V Pharmaceutics. 2022; 14(11).

PMID: 36365209 PMC: 9693281. DOI: 10.3390/pharmaceutics14112391.